Skip to content

Effect of preoperative dexmedetomidine nasal drops on postoperative delirium in elderly patients with colorectal cancer in anxious state

Effect of preoperative dexmedetomidine nasal drops on postoperative delirium in elderly patients with colorectal cancer in anxious state

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094478
Enrollment
Unknown
Registered
2024-12-24
Start date
2024-12-25
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Interventions

Dexmedetomidine nasal drops group:Dexmedetomidine hydrochloride nasal drops from 20:00 to 21:30 the day before surgery.
Normal saline control group:The day before surgery 20:00 to 21:30 equal volume normal saline nasal drip.

Sponsors

The First Affiliated Hospital of Hebei North University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 79 Years

Inclusion criteria

Inclusion criteria: (1)Age 60 ~ 79 years old;(2)ASA Grade II/III;(3)Elderly patients undergoing abdominal tumor surgery under general anesthesia;(4)Preoperative Amsterdam Preoperative Anxiety and Information Needs Scale score greater than 11 points;(5)Patients and their families clearly understand, voluntarily participate in the study, and sign informed.

Exclusion criteria

Exclusion criteria: (1)Patients who can't sign informed consent;(2)Patients who do not understand Chinese;(3)Severe respiratory or cardiovascular disease;(4)Severe liver disease (Childs-Pugh score Class C);(5)Severe audio-visual impairments hinder communication;(6)Study drugs for allergic reactions, allergies, or contraindications;(7)Patients with dementia or preoperative MMSE score of illiterate patients 15;(11)Severe snoring;(12)obesity(BMI>23.9kg/m^2);(13)Severe sinus bradycardia (HR<=45 beats/min) and atrioventricular block of degree ? or above;(14)No post-operative follow-up is possible;(15)There are other circumstances in which the investigator considers it inappropriate to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Incidence of delirium within 7 days after surgery;

Secondary

MeasureTime frame
Postoperative recovery quality;Postoperation pain;Incidence of postoperative agitation;Incidence of postoperative nausea and vomiting;Anxiety level on the day before operation and the morning of operation (before operation);The number of intraoperative episodes of hypotension/hypertension (defined as MAP exceeding 20% of the baseline value) for 1 consecutive minute were recorded.;The number and dosage of vasoactive drugs used during the operation;Duration of stay in PACU;Intraoperative atropine dose;

Countries

China

Contacts

Public ContactYao Jie

The First Affiliated Hospital of Hebei North University

jingjie1229@163.com+86 155 3039 0226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026